Endotoxin immunity and the development of the systemic inflammatory response syndrome in critically ill children

Intensive Care Medicine

Volumn 32, Issue 2, 2006, Pages 286-294

  Stephens, R C M ^a   Fidler, K ^a   Wilson, P ^b   Barclay, G R ^c   Mythen, M G ^a   Dixon, G L J ^a   Turner, M W ^a   Klein, N J ^a   Peters, M J ^b  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b GREAT ORMOND STREET HOSPITAL   (United Kingdom)

^c SCOTTISH NATIONAL BLOOD TRANSFUSION SERVICE   (United Kingdom)

Author keywords

Critical illness; Endotoxin; Endotoxin core antibodies; Immunity; Paediatric; Systemic inflammatory response syndrome

Indexed keywords

C REACTIVE PROTEIN; ENDOTOXIN; IMMUNOGLOBULIN G; MANNOSE BINDING LECTIN;

ARTICLE; CHILD; CONTROLLED STUDY; CRITICAL ILLNESS; DEMOGRAPHY; FEMALE; HEAD INJURY; HOSPITAL ADMISSION; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; MALE; MULTIPLE ORGAN FAILURE; PATIENT CODING; POSTOPERATIVE PERIOD; SAMPLE SIZE; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; CRITICAL ILLNESS; ENDOTOXEMIA; FEMALE; HUMANS; INFANT; MALE; RISK FACTORS; STATISTICS, NONPARAMETRIC; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;

EID: 32844467045     PISSN: 03424642     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00134-005-0019-z     Document Type: Article

References (40)

1. Brun-Buisson C (2000) The epidemiology of the systemic inflammatory response. Intensive Care Med 26:64-74
2. Fidler KJ, Wilson P, Davies JC, Turner MW, Peters MJ, Klein NJ (2004) Increased incidence and severity of the systemic inflammatory response syndrome in patients deficient in mannose-binding lectin. Intensive Care Med 30:1438-1445
3. Stuber F, Petersen M, Bokelmann F, Schade U (1996) A genomic polymorphism within the tumor necrosis factor locus influences plasma tumor necrosis factor-alpha concentrations and outcome of patients with severe sepsis. Crit Care Med 24:381-384
4. Garred P, Strom J, Quist L, Taaning E, Madsen HO (2003) Association of mannose-binding lectin polymorphisms with sepsis and fatal outcome, in patients with systemic inflammatory response syndrome. J Infect Dis 188:1394-1403
5. Medzhitov R, Preston-Hurlburt P, Janeway CA Jr (1997) A human homologue of the Drosophila Toll protein signals activation of adaptive immunity. Nature 388:394-397
6. Tlaskalova-Hogenova H, Stepankova R, Hudcovic T, Tuckova L, Cukrowska B, Lodinova-Zadnikova R, Kozakova H, Rossmann P, Bartova J, Sokol D, Funda DP, Borovska D, Rehakova Z, Sinkora J, Hofman J, Drastich P, Kokesova A (2004) Commensal bacteria (normal microflora), mucosal immunity and chronic inflammatory and autoimmune diseases. Immunol Lett 93:97-108
7. Suffredini AF, Hochstein HD, McMahon FG (1999) Dose-related inflammatory effects of intravenous endotoxin in humans: evaluation of a new clinical lot of Escherichia coli O:113 endotoxin. J Infect Dis 179:1278-1282
8. Stephens R, Mythen M (2000) Endotoxin immunization. Intensive Care Med 26:129-136
9. Oppenheim BA, Barclay GR, Morris J, Knox F, Barson A, Drucker DB, Crawley BA, Morris JA (1994) Antibodies to endotoxin core in sudden infant death syndrome. Arch Dis Child 70:95-98
10. Bennett-Guerrero E, Ayuso L, Hamilton-Davies C, White WD, Barclay GR, Smith PK, King SA, Muhlbaier LH, Newman MF, Mythen MG (1997) Relationship of preoperative antiendotoxin core antibodies and adverse outcomes following cardiac surgery. JAMA 277:646-650
11. Bennett-Guerrero E, Panah MH, Barclay GR, Bodian CA, Winfree WJ, Andres LA, Reich DL, Mythen MG (2001) Decreased endotoxin immunity is associated with greater mortality and/or prolonged hospitalization after surgery. Anesthesiology 94:992-998
12. Goldie AS, Fearon KC, Ross JA, Barclay GR, Jackson RE, Grant IS, Ramsay G, Blyth AS, Howie JC (1995) Natural cytokine antagonists and endogenous antiendotoxin core antibodies in sepsis syndrome. The Sepsis Intervention Group. JAMA 274:172-177
13. Mathew JP, Grocott HP, Phillips-Bute B, Stafford-Smith M, Laskowitz DT, Rossignol D, Blumenthal JA, Newman MF (2003) Lower endotoxin immunity predicts increased cognitive dysfunction in elderly patients after cardiac surgery. Stroke 34:508-513
14. Strutz F, Heller G, Krasemann K, Krone B, Muller GA (1999) Relationship of antibodies to endotoxin core to mortality in medical patients with sepsis syndrome. Intensive Care Med 25:435-444
15. American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference: definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. (1992) Crit Care Med 20:864-874
16. Leteurtre S, Martinot A, Duhamel A, Proulx F, Grandbastien B, Cotting J, Gottesman R, Joffe A, Pfenninger J, Hubert P, Lacroix J, Leclerc F (2003) Validation of the paediatric logistic organ dysfunction (PELOD) score: prospective, observational, multicentre study. Lancet 362:192-197
17. Barclay GR, Scott BB (1987) Serological relationships between Escherichia coli and Salmonella smooth and rough-mutant lipopolysaccharides revealed by ELISA for human IgG anti-endotoxin antibodies. Infect Immun 55:2706-2714
18. Barclay GR (1995) Bacterial endotoxins: lipopolysaccharides from genes to therapy. In: Levin J, Alving CR, Munford RS, Redl H (eds) Progress in clinical and biological research. Wiley, New York, pp 263-272
19. Bennett-Guerrero E, Barclay GR, Weng PL, Bodian CA, Feierman DE, Vela-Cantos F, Mythen MG (2001) Endotoxin-neutralizing capacity of serum from cardiac surgical patients. J Cardiothorac Vasc Anesth 15:451-454
20. Jackson SK, Parton J, Shortland G, Stark JM, Thompson EN (1990) Serum immunoglobulins to endotoxin core glycolipid: acute leukaemia and other cancers. Arch Dis Child 65:771-773
21. Burd RS, Battafarano RJ, Cody CS, Farber MS, Ratz CA, Dunn DL (1993) Anti-endotoxin monoclonal antibodies inhibit secretion of tumor necrosis factor-alpha by two distinct mechanisms. Ann Surg 218:250-259
22. Scott BB, Barclay GR (1990) IgG antibodies to Gram-negative endotoxin in human sera. II. Opsonic activity of cross-reactive antibodies to endotoxin core for rough and smooth bacteria. Serodiagn Immunother Infect Dis 4:39-51
23. Hodgson JC, Barclay GR, Hay LA, Moon GM, Poxton IR (1995) Prophylactic use of human endotoxin-core hyperimmune gammaglobulin to prevent endotoxaemia in colostrum-deprived, gnotobiotic lambs challenged orally with Escherichia coli. FEMS Immunol Med Microbiol 11:171-180
24. Bennett-Guerrero E, Panah MH, Barclay GR, Bodian CA, Wanda PH, Winfree J, Andres LA, Reich DL, Mythen MG (2001) Decreased Endotoxin Immunity Is Associated with Greater Mortality and/or Prolonged Hospitalization after Surgery. Anesthesiology 94:992-998
25. Bennett-Guerrero E, Ayuso L, Hamilton-Davies C, White WD, Barclay GR, Smith PK, King SA, Muhlbaier LH, Newman MF, Mythen MG (1997) Relationship of preoperative antiendotoxin core antibodies and adverse outcomes following cardiac surgery. JAMA 277:646-650
26. Bennett-Guerrero E, Barclay GR, Weng PL, Bodian CA, Feierman DE, Vela-Cantos F, Mythen MG (2001) Endotoxin-neutralizing capacity of serum from cardiac surgical patients. J Cardiothorac Vasc Anesth 15:451-454
27. Hamilton-Davies C, Barclay GR, Machin SJ, Webb AR (1995) Relationship between endotoxin immune status and outcome following cardiac valve surgery. Eur Soc Anesthesiol 74:34
28. Mythen MG, Barclay GR, Hamilton-Davies C, Webb AR, Machin SJ (1993) The role of endotoxin immunity, neutrophil degranulation and contact activation in the pathogenesis of post-operative organ failure. Blood Coagul Fibrinolysis 4:995-1005
29. Mythen MG, Webb AR (1995) Perioperative plasma volume expansion reduces the incidence of gut mucosal hypoperfusion during cardiac surgery. Arch Surg 130:423-429
30. Dixon GL, Heyderman RS, van der LP, Klein NJ (2004) High-level endothelial E-selectin (CD62E) cell adhesion molecule expression by a lipopolysaccharide-deficient strain of Neisseria meningitidis despite poor activation of NF-kappaB transcription factor. Clin Exp Immunol 135:85-93
31. Rothenburger M, Soeparwata R, Deng MC, Schmid C, Berendes E, Tjan TD, Wilhelm MJ, Erren M, Bocker D, Scheld HH (2001) Prediction of clinical outcome after cardiac surgery: the role of cytokines, endotoxin, and anti-endotoxin core antibodies. Shock 16:44-50
32. Barclay GR (1995) Endogenous endotoxin-core antibody (EndoCAb) as a marker of endotoxin exposure and a prognostic indicator: a review. Prog Clin Biol Res 392:263-272
33. Rothenburger M, Soeparwata R, Deng MC, Berendes E, Schmid C, Tjan TD, Wilhelm MJ, Erren M, Bocker D, Scheld HH (2001) The impact of anti-endotoxin core antibodies on endotoxin and cytokine release and ventilation time after cardiac surgery. J Am Coll Cardiol 38:124-130
34. Mythen MG, Barclay GR, Purdy G, Hamilton-Davies C, Mackie IJ, Webb AR, Machin SJ (1993) The role of endotoxin immunity, neutrophil degranulation and contact activation in the pathogenesis of post-operative organ dysfunction. Blood Coagul Fibrinolysis 4:999-1005
35. O'Dwyer ST, Michie HR, Ziegler TR, Revhaug A, Smith RJ, Wilmore DW (1988) A single dose of endotoxin increases intestinal permeability in healthy humans. Arch Surg 123:1459-1464
36. Maury E, Blanchard HS, Chauvin P, Guglielminotti J, Alzieu M, Guidet B, Offenstadt G (2003) Circulating endotoxin and antiendotoxin antibodies during severe sepsis and septic shock. J Crit Care 18:115-120
37. Nys M, Damas P, Joassin L, Lamy M (1993) Sequential anti-core glycolipid immunoglobulin antibody activities in patients with and without septic shock and their relation to outcome. Ann Surg 217:300-306
38. Hamilton-Davies C, Barclay GR, Machin SJ, Webb AR (1996) Passive immunisation with IgG endotoxin core antibody hyperimmune fresh frozen plasma. Vox Sang 71:165-169
39. Rashid M, Stephens R, Siva M, Grocott M, Burdett E, Turner D, Mythen M (2004) Regional variation in anti-endotoxin core antibody levels in healthy and preoperative surgical populations. Crit Care 7:199
40. Goldstein B, Giroir B, Randolph A (2005) International pediatric sepsis consensus conference: definitions for sepsis and organ dysfunction in pediatrics. Pediatr Crit Care Med 6:2-8